"Comparison with Mesoblast Ltd (ASX: MSB): Whilst both companies...

"Comparison with Mesoblast Ltd (ASX: MSB):
Whilst both companies are developing allogeneic
stem cell platforms, there are some differences
between the two companies. Perhaps the most
significant is how the two companies source their
cells. As discussed, Cynata will manufacture its
cells from pluripotent cells, taking advantage of
their prodigious expansion capacity. In contrast,
MSB source their cells from the bone marrow of
appropriately-qualified adult donors".

From a very good summary:

http://www.ecoquest.com.au/wp-content/uploads/2012/07/12.12.05.Background-on-Cynta-Inc.pdf


I know which one I would prefer to be a donor for. Giving blood is much easier than bone marrow.

I hope (and think) this company also has a "prodigious expansion capacity"

I don't think I'm the only hack having a look either.